Brookfield Business Partners L. – Consensus Indicates Potential 92.1% Upside

Brookfield Business Partners L. found using ticker (BBU) have now 3 analysts in total covering the stock. The consensus rating is ‘Buy’. The range between the high target price and low target price is between 49.89 and 42.02 with a mean TP of 44.64. Given that the stocks previous close was at 23.24 this now indicates there is a potential upside of 92.1%. There is a 50 day moving average of 21.82 and the 200 moving average now moves to 25.69. The company has a market cap of $1,777m. You can visit the company’s website by visiting: https://bbu.brookfield.com

The potential market cap would be $3,412m based on the market concensus.

Brookfield Business Partners L.P. is a private equity firm specializes in acquisition. The firm typically invests in business services, construction, energy, and industrials sector. It prefers to take majority stake in companies. The firm seeks returns of at least 15% on its investments. Brookfield Business Partners L.P. is based in Hamilton, Bermuda. Brookfield Business Partners L.P. operates as a subsidiary of Brookfield Asset Management Inc.

Share on:

Written by: Charlotte Edwards

Find more news, interviews, share price & company profile here for:

Latest Company News

Likewise granted approval for 20,000 sq ft expansion of Newport facility

Likewise Group has received planning permission to extend its Newport warehouse by 20,000 sq ft, creating a 55,000 sq ft distribution hub. The development will be funded through internal cash flow.

Cerillion secures £17.3m follow-on contracts with major European customer

Cerillion has signed two agreements worth a combined £17.3 million with an existing European customer, following an £8 million services contract announced in May 2025.

Avation reports US$110m revenue and strengthened balance sheet for FY25

Avation expects revenue of around US$110 million for the year to 30 June 2025. The company has reduced outstanding bond debt to US$298 million through repurchases and improved its credit ratings with Moody’s and Fitch.

JPMorgan European Discovery Trust reports strong performance uplift in latest factsheet

JPMorgan European Discovery Trust reported a 5.37% share price rise in July 2025, outpacing NAV and its benchmark. Year-to-date, the share price is up 34.17%, supported by strong small-cap performance and effective stock selection.

Golden Matrix reports record August revenue of $17.8m, up 18% year-on-year

Golden Matrix posted record August revenues of $17.8m, up 18% from last year, with July revenues also rising 24% to $15.7m. Strong performance came from Meridianbet’s sports betting and RKings’ tournaments, positioning the group for record Q3 results.

HUTCHMED to present new lung cancer and oncology data at WCLC and CSCO 2025

HUTCHMED announced that updated data on savolitinib in NSCLC and other pipeline compounds will be presented at the World Conference on Lung Cancer in Barcelona and the CSCO Annual Meeting in China this September. Presentations include studies on savolitinib, surufatinib, fruquintinib and first-in-human results for HMPL-653.